Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease

Org Lett. 2002 Dec 12;4(25):4475-8. doi: 10.1021/ol027013x.

Abstract

[reaction: see text] In this, the first of two letters, we outline the use of the pyrrolidine-5,5-trans-lactam template to design small, neutral, mechanism-based inhibitors of hepatitis C NS3/4A protease. The hitherto unreported reaction of the acyl iminium ion precursor 4 with dialkyl-substituted silyl ketene acetals (e.g., 8b) is described. Compound 12b, with a spirocyclobutyl P1 substituent and a cyclopropylacyl substituent on the lactam nitrogen, has a k(obs)/I of 400 M(-)(1) s(-)(1) and demonstrates activity in a replicon cell-based surrogate HCV assay.

MeSH terms

  • Cell Line
  • Drug Design
  • Drug Stability
  • Hepacivirus / drug effects
  • Hepacivirus / enzymology*
  • Humans
  • Lactams / chemical synthesis*
  • Lactams / chemistry
  • Molecular Structure
  • Protease Inhibitors / chemical synthesis*
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*
  • Pyrrolidines / chemical synthesis*
  • Pyrrolidines / chemistry
  • Serine Endopeptidases / metabolism*
  • Viral Nonstructural Proteins / antagonists & inhibitors*
  • Viral Nonstructural Proteins / metabolism

Substances

  • Lactams
  • NS3 protein, hepatitis C virus
  • Protease Inhibitors
  • Pyrrolidines
  • Viral Nonstructural Proteins
  • Serine Endopeptidases